Hot Pursuit     07-Mar-25
Gland Pharma Ltd up for third straight session
Gland Pharma Ltd is quoting at Rs 1663.3, up 2.05% on the day as on 12:49 IST on the NSE. The stock is down 5.11% in last one year as compared to a 0.98% jump in NIFTY and a 6.33% jump in the Nifty Pharma index.

Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 1663.3, up 2.05% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.03% on the day, quoting at 22550.8. The Sensex is at 74315, down 0.03%. Gland Pharma Ltd has gained around 12.55% in last one month.

Meanwhile, Nifty Pharma index of which Gland Pharma Ltd is a constituent, has gained around 5.76% in last one month and is currently quoting at 20423.35, down 0.03% on the day. The volume in the stock stood at 95455 shares today, compared to the daily average of 2.64 lakh shares in last one month.

The PE of the stock is 23.95 based on TTM earnings ending December 24.

Previous News
  Gland Pharma receives USFDA approval for Cetrorelix Acetate for Injection
 ( Corporate News - 29-Apr-24   10:49 )
  Gland Pharma receives USFDA approval for Acetaminophen Injection 10 mg/mL
 ( Corporate News - 03-Apr-25   11:22 )
  Gland Pharma’s Visakhapatnam facility gets 3 USFDA observations
 ( Hot Pursuit - 25-Feb-25   16:03 )
  Gland Pharma Ltd up for third straight session
 ( Hot Pursuit - 17-Jan-25   13:05 )
  Gland Pharma Ltd down for fifth straight session
 ( Hot Pursuit - 10-Nov-22   13:36 )
  Gland Pharma gets EIR from USFDA for Pashamylaram facility
 ( Hot Pursuit - 18-Jan-25   10:50 )
  Gland Pharma consolidated net profit rises 9.79% in the March 2022 quarter
 ( Results - Announcements 19-May-22   17:16 )
  Gland Pharma consolidated net profit declines 19.55% in the September 2023 quarter
 ( Results - Announcements 06-Nov-23   17:42 )
  Nifty slides below 23,950; pharma shares decline for 2nd day
 ( Market Commentary - Mid-Session 05-Nov-24   11:34 )
  Gland Pharma Q2 PAT declines 19% YoY to Rs 194 cr
 ( Hot Pursuit - 07-Nov-23   10:26 )
  Gland Pharma appoints Srinivas Sadu as Executive Chairman and CEO
 ( Corporate News - 08-Jun-24   12:56 )
Other Stories
  HDFC Bank Q4 PAT rises 7% YoY to Rs 17,616 cr; NII rises 10%
  19-Apr-25   18:04
  Yes Bank Q4 PAT climbs 63% YoY to Rs 738 cr
  19-Apr-25   16:20
  Mastek Q4 PAT slides 14% QoQ to Rs 81 cr; recommends final dividend of Rs 16/sh
  19-Apr-25   14:31
  Tata Elxsi posts PAT of Rs 172 crore in Q4; EBITDA margin at 20.5%
  19-Apr-25   12:47
  Mahindra EPC records more than fourfold rise in Q4 PAT
  19-Apr-25   11:04
  Just Dial Q4 PAT climbs 36% YoY to Rs 158 cr
  19-Apr-25   10:02
  Jio Financial Services Q4 PAT rises 2% YoY to Rs 316 cr
  19-Apr-25   08:57
  HDFC Life Q4 PAT climbs 16% YoY to Rs 476 cr
  17-Apr-25   17:32
  Infosys Q4 PAT rises 3% QoQ to Rs 7,038 cr; declares dividend of Rs 22/sh
  17-Apr-25   17:25
  HDFC AMC rises after Q4 PAT jumps 18% YoY to Rs 639 cr; declares final dividend of Rs 90/sh
  17-Apr-25   17:11
Back Top